JDRF is the leading supporter of T1D research globally, investing USD$2.25B since 1970 with $191M invested in Australia. We evaluate the Australian and global research landscape and support the most promising programs from learning, to lab, to life-changing breakthroughs. We mobilise a vast network of people who work together in pursuit of a world without T1D. In 2019 alone, research breakthroughs in our mission to cure, treat and prevent T1D have included huge advances in beta cell replacement, new targets for complication treatments, and the first ever therapy to delay the onset of T1D.

Scroll down for the latest on our fight to eradicate T1D.